Jiangman Zhao

A regulator-based immunoscore predicts prognosis and immunotherapy response in gastric cancer

Immune checkpoint inhibitors (ICIs) have improved treatment outcomes in gastric cancer (GC); however, only a subset of patients benefit due to tumor heterogeneity. Current biomarkers have limited predictive value, highlighting the need for improved stratification strategies. We a...